Mirati Therapeutics, Inc. Annual Return On Equity in % from 2014 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Mirati Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2022.
  • Mirati Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was -82.2 %, a 36% decline year-over-year.
  • Mirati Therapeutics, Inc. annual Return On Equity for 2022 was -66.1 %, a 38.2% decline from 2021.
  • Mirati Therapeutics, Inc. annual Return On Equity for 2021 was -47.8 %, a 5.92% decline from 2020.
  • Mirati Therapeutics, Inc. annual Return On Equity for 2020 was -45.1 %, a 16.8% increase from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -66.1 -18.3 -38.2% Jan 1, 2022 Dec 31, 2022
2021 -47.8 -2.67 -5.92% Jan 1, 2021 Dec 31, 2021
2020 -45.1 +9.11 +16.8% Jan 1, 2020 Dec 31, 2020
2019 -54.2 -5.68 -11.7% Jan 1, 2019 Dec 31, 2019
2018 -48.6 +23 +32.2% Jan 1, 2018 Dec 31, 2018
2017 -71.6 +40.1 +35.9% Jan 1, 2017 Dec 31, 2017
2016 -112 -42.6 -61.7% Jan 1, 2016 Dec 31, 2016
2015 -69.1 +144 +67.5% Jan 1, 2015 Dec 31, 2015
2014 -213 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.